130 related articles for article (PubMed ID: 43342)
1. Failure of pyridoxine to effect neuroleptic-induced hyperprolactinemia in psychotic patients.
Brambilla F; Penati G; Freni S; Bottinelli S; Maffei C; Maiella V
J Endocrinol Invest; 1979; 2(3):299-302. PubMed ID: 43342
[TBL] [Abstract][Full Text] [Related]
2. Tolerance to the prolactin-elevating effect of neuroleptics.
Brown WA; Laughren TP
Psychiatry Res; 1981 Dec; 5(3):317-22. PubMed ID: 6119716
[TBL] [Abstract][Full Text] [Related]
3. Prolactin responses to neuroleptics in normal and schizophrenic subjects.
Gruen PH; Sachar EJ; Langer G; Altman N; Leifer M; Frantz A; Halpern FS
Arch Gen Psychiatry; 1978 Jan; 35(1):108-16. PubMed ID: 23087
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography measurement of dopamine D₂ receptor occupancy in the pituitary and cerebral cortex: relation to antipsychotic-induced hyperprolactinemia.
Arakawa R; Okumura M; Ito H; Takano A; Takahashi H; Takano H; Maeda J; Okubo Y; Suhara T
J Clin Psychiatry; 2010 Sep; 71(9):1131-7. PubMed ID: 20361897
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of hyperprolactinemia in schizophrenia: association with typical and atypical antipsychotic treatment.
Montgomery J; Winterbottom E; Jessani M; Kohegyi E; Fulmer J; Seamonds B; Josiassen RC
J Clin Psychiatry; 2004 Nov; 65(11):1491-8. PubMed ID: 15554761
[TBL] [Abstract][Full Text] [Related]
6. [Effect of high single doses of bromocriptine in schizophrenic patients with elevated serum prolactin levels and extrapyramidal side effects associated with neuroleptic treatment (author's transl)].
Ringwald E; Lustig A; Moscovici M; Spiegel R; Vamos E
Pharmakopsychiatr Neuropsychopharmakol; 1980 Nov; 13(6):318-24. PubMed ID: 6111093
[TBL] [Abstract][Full Text] [Related]
7. Relationship between prolactin levels and subjective endocrine-related adverse effects in patients with schizophrenia receiving long-term treatment with amisulpride.
Kim EY; Kim SH; Lee NY; Jung DC; Kim YS; Ahn YM
Pharmacopsychiatry; 2012 Mar; 45(2):57-63. PubMed ID: 22411694
[TBL] [Abstract][Full Text] [Related]
8. Effects of cabergoline on hyperprolactinemia, psychopathology, and sexual functioning in schizophrenic patients.
Kalkavoura CS; Michopoulos I; Arvanitakis P; Theodoropoulou P; Dimopoulou K; Tzebelikos E; Lykouras L
Exp Clin Psychopharmacol; 2013 Aug; 21(4):332-41. PubMed ID: 23834553
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine tests during treatment with neuroleptic drugs I. Plasma prolactin response to haloperidol challenge.
Kolakowska T; Braddock L; Wiles D; Franklin M; Gelder M
Br J Psychiatry; 1981 Nov; 139():400-4. PubMed ID: 6120731
[TBL] [Abstract][Full Text] [Related]
10. [The effect of propranolol, neuroleptics and their combination on serum prolactin levels of schizophrenic patients].
Elizur A; Segal Z; Yeret A; Aboo-Shach M; Ben-David M
Harefuah; 1979 Sep; 97(5-6):101-4. PubMed ID: 44254
[No Abstract] [Full Text] [Related]
11. Hyperprolactinemia in response to antipsychotic drugs: characterization across comparative clinical trials.
Kinon BJ; Gilmore JA; Liu H; Halbreich UM
Psychoneuroendocrinology; 2003 Apr; 28 Suppl 2():69-82. PubMed ID: 12650682
[TBL] [Abstract][Full Text] [Related]
12. Increased serum prolactin levels during phenothiazine and butyrophenone treatment of six postpartum women.
Goode DJ; Meltzer HY; Fang VS
Psychoneuroendocrinology; 1980 Dec; 5(4):345-51. PubMed ID: 6111101
[No Abstract] [Full Text] [Related]
13. [Difference in prolaction response of schizophrenic patients to equivalent doses of haloperidol, remoxipride and sulpiride].
Liu KL; Lung FW
Kaohsiung J Med Sci; 1996 Dec; 12(12):685-90. PubMed ID: 9011126
[TBL] [Abstract][Full Text] [Related]
14. Lack of tolerance to long-term neuroleptic treatment in dopamine tuberoinfundibular system.
Chouinard G; Annable L; Jones BD; Collu R
Acta Psychiatr Scand; 1981 Nov; 64(5):353-62. PubMed ID: 6126066
[TBL] [Abstract][Full Text] [Related]
15. Stability of serum neuroleptic and prolactin concentrations during short- and long-term treatment of schizophrenic patients.
Rao ML; Brown WA
Psychopharmacology (Berl); 1987; 93(2):237-42. PubMed ID: 2892222
[TBL] [Abstract][Full Text] [Related]
16. Effect of neuroleptic withdrawal on plasma prolactin: a possible marker of receptor adaptation.
Kirkpatrick B; Buchanan RW; Maeda K; Carpenter WT; Jauch D; Tamminga CA
Biol Psychiatry; 1989 Jun; 26(2):131-8. PubMed ID: 2567610
[TBL] [Abstract][Full Text] [Related]
17. The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia.
David SR; Taylor CC; Kinon BJ; Breier A
Clin Ther; 2000 Sep; 22(9):1085-96. PubMed ID: 11048906
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of hyperprolactinemia after long-term haloperidol use in patients with chronic schizophrenia.
Jung DU; Seo YS; Park JH; Jeong CY; Conley RR; Kelly DL; Shim JC
J Clin Psychopharmacol; 2005 Dec; 25(6):613-5. PubMed ID: 16282852
[No Abstract] [Full Text] [Related]
19. Is second-generation antipsychotic-induced hyperprolactinemia due to biologically active prolactin or to biologically inactive macroprolactin? Results from a prospective study.
Tschoner A; Engl J; Rettenbacher MA; Kaser S; Ott HW; Fleischhacker WW; Patsch JR; Ebenbichler CF
J Clin Psychiatry; 2009 Feb; 70(2):293-4. PubMed ID: 19265646
[No Abstract] [Full Text] [Related]
20. Hysterical neurosis of the conversion type: therapeutic activity of neuroleptics with different hyperprolactinemic potency.
Rampello L; Raffaele R; Nicoletti G; Le Pira F; Malaguarnera M; Drago F
Neuropsychobiology; 1996; 33(4):186-8. PubMed ID: 8840341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
